-
The party responded to sending a circle of friends to let montmorillonite go out of stock: a record has been made at the police station; Beijing currently admits 3% to 4% of infected people
Time of Update: 2023-02-03
Daily medical appointmentsDaily medical appointments1 The party responded to sending a circle of friends to let the montmorillonite go out of stock: a record has been made at the police station1 The p
-
The first patient enrolled in the clinical trial of the innovative drug MDM2-p53 antagonist in the treatment of dedifferentiated liposarcoma in China
Time of Update: 2023-02-02
*For medical professionals onlyOn January 5, 2023, Boehringer Ingelheim announced that its innovative drug MDM2-p53 antagonist BI 907828 for the first-line treatment of dedifferentiated liposarcoma (D
-
Little tomatoes that teach you how to improve age spots
Time of Update: 2023-02-02
Preliminary review: Li Song Responsible editor: Zhang Jiazhen Review: Peng Zonglu Age spots are a kind of skin degeneration in the elderly, clinically manifested as pigment patches of different sizes scattered on the surface of the skin, most of which are brownish-brown.
-
In the treatment of alkalized urine in patients with gout nephropathy, Professor Zou Hejian summarized these points
Time of Update: 2022-10-01
*For medical professionals onlyIs it really easy to alkalize urine?It has been reported that the prevalence of gout in China ranges from 0. 86% to 2. 20% in various regions, and from 2015 to 2019, the
-
Supplement nutrition after school starts, choose four foods for your child, nutritious and delicious, and supplement vitamins
Time of Update: 2022-09-08
In the cool autumn, it is recommended that you eat dates for the treatment of hypotension caused by temper deficiency, diarrhea, yin blood deficiency caused by women's dirty mania, and people with weakness after illness eat jujube also have a good tonic effect; This product is sweet and warm, moisturizing and nourishing the blood, and the sweet taste can alleviate the medicinal properties, which is used for qi and blood deficiency and to alleviate the toxicity of the drug.
-
Bone Marrow Transplant: Comparison of Fludarabine-Melphalan and Fludarabine-Triendosulfan as Conditioning Before Allogeneic Hematopoietic Cell Transplantation
Time of Update: 2022-08-12
In this study, a research team compared outcomes after two commonly used single alkylating agent-based conditioning regimens in the intermediate TCI score category, fludarabine/melphalan 140 mg/m 2 (FluMel) and Fludarabine/triendosulfan 42 g/m 2 (FluTreo) for acute myeloid leukemia (AML) patients in complete remission (CR) .
-
Article Summary: Genetic Testing in Kidney Cancer
Time of Update: 2022-06-01
Although molecular typing based on genetic testing has not been used as a reference for mRCC treatment in domestic and foreign guidelines and consensuses, in recent domestic and foreign studies, gene mutations have a certain role in the clinical diagnosis, efficacy evaluation, and prognosis prediction of renal cancer.
-
2022 EBMT Research progress of ruxolitinib in the treatment of graft-versus-host disease
Time of Update: 2022-04-30
OS10-03 Title: Comparison of the efficacy of ruxolitinib and best available therapy in the treatment of hormone-refractory aGVHD: a post hoc analysis of remission in different involved organs in the REACH2 study Background of the multicenter, randomized phase 3 clinical trial REACH2 ( NCT02913261) showed that in patients with hormone-refractory aGVHD, ruxolitinib improved overall response rate (ORR) at day 28 and durable ORR at day 56 compared with best available therapy (BAT) (key secondary end point; 39.
-
Which undifferentiated arthritis progresses to RA
Time of Update: 2022-04-28
Conclusions: This large prospective study suggests that MRI is most valuable in ACPA-negative UA patients with oligoarthritis; MRI-negative (without osteitis, synovitis, or tenosynovitis) helps prevent overtreatment .
-
The only new basal insulin analog on the list
Time of Update: 2022-04-28
Figure 2 CONFIRM study results Poor blood sugar control will bring long-term complications and increased risk of death, which will further increase the health and economic burden of patients [8] .
Summary Taking efficacy, safety, and cost-effectiveness as the consideration criteria, WHO will include long-acting insulin analogs in EML in 2021 .
-
How to choose imipenem, meropenem, biapenem and ertapenem
Time of Update: 2022-02-23
Imipenem, meropenem, biapenem, and ertapenem are four carbapenem antibiotics commonly used in clinic.
1 There are four carbapenem antibiotics that have been included in the 2020 medical insurance list: imipenem, cilastatin, meropenem, biapenem, and ertapenem .
-
Pancreatology: Association between pre-existing diabetes and severity of acute pancreatitis
Time of Update: 2022-01-22
diagnosis The results of the study showed that AP patients had pre-existing DM in 270, of which 252 (93.
The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry.
-
2021 ASH is the first to see Professor Zhang Xian sharing CAR-T treatment experience and cutting-edge progress
Time of Update: 2021-12-04
In recent years, chimeric antigen receptor T cell (CAR-T) therapy has achieved breakthrough results in the field of hematological tumors, and CAR-T-related new drugs have also been launched in China, but there are still many problems that urgently need to be further improved in clinical research, such as Persistence, the influencing factors of curative effect and how to choose effective targets and other issues .
-
Radiology: Breast MRI during neoadjuvant chemotherapy must pay attention to this sign
Time of Update: 2021-12-03
In addition, it can also be vascularRecently, a study published in the journal Radiology explored the relationship between the lack of BPE inhibition and NAC treatment response in HR-positive and HR-negative cohorts, providing a reference for accurate disease identification and further evaluation of treatment effects .
-
2021 CSCO highlights you missed are all here
Time of Update: 2021-11-16
2021 CSCO expert interview | Professor Zhang Yizhu: new progress in the treatment of lymphoma in children and adolescents 4.
2021 CSCO expert interview | Professor Deng Qi talks about the treatment progress of extramedullary multiple myeloma 6.
